EU grants Da Volterra EUR 20m loan to speed up development of innovative solutions for the prevention and treatment of antibiotic-resistant infections

September 22, 2017

Paris (France) – 22 September 2017 – The European Investment Bank (EIB) and biopharmaceutical company Da Volterra announced today that they have entered into a EUR 20m financing agreement.

Download Communique